Newborn screening is one of the most successful public health initiatives in the United States. Nearly 4 million babies are born each year in the U.S. Every baby is tested for a list of diseases or conditions, based on each state's panel of tests. These newborn screening tests enable early identification of conditions - which allows for the earliest possible intervention or treatment.
Discover facts about Newborn Screening
Newborn screening began in the U.S. in the 1960s with a test for PKU (Phenylketonuria).
The Recommended Uniform Screening Panel (RUSP) is a U.S. guideline that recommends conditions states add to their newborn screening panels.
1 in 300 newborns has a condition that is detectable through newborn screening.
Less than 35% of all children born around the world receive screening for at least one condition.
"Maggie's story is a really classic one for why we should do newborn screening."
Two-year-old Maggie was diagnosed with MPS I, a progressively debilitating genetic disorder, just after her first birthday.
Her diagnostic odyssey could have been avoided with newborn screening.
To learn more about this family, read an interview with Maggie's mom.
When Georgia was first born, her mom Kari was like most moms. She didn't really know anything about newborn screening. Georgia was identified with Infantile Onset Pompe disease following screening in Missouri.
Listen to Kari beautifully describe what newborn screening meant to Georgia and her family.